News
Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoY
2 Apr 24
Earnings, News
Vaccinex Announces It Has Entered Into Eight New Antibody Discovery Agreements Integrating Use Of Its Proprietary ActivMAb Platform To Select Antibodies Against Difficult-To-Drug Transmembrane Protein Targets
21 Feb 24
Biotech, News, General
Why Vaccinex (VCNX) Stock Is Trading Lower
15 Feb 24
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
14 Feb 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
9 Feb 24
Movers
Why Vaccinex (VCNX) Stock Is Popping Off
7 Feb 24
News
Vaccinex Announces Pricing Of $3.7M Private Placement For The Sale Of An Aggregate 3,838,544 Shares Of Common Stock
7 Feb 24
News, Offerings
Press releases
Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
27 Mar 24
Press Releases
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
21 Feb 24
News, Contracts, Press Releases, General
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
7 Feb 24
News, Financing, Press Releases